Research programme: G protein-coupled receptor 119 agonists - KalypsysAlternative Names: GPR119
Latest Information Update: 16 Jul 2016
At a glance
- Originator Kalypsys
- Mechanism of Action G protein-coupled receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes - Diabetes mellitus
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in USA